Martyn Kim Robinson

Title: Martyn Kim Robinson: Innovator in Antibody Development

Introduction

Martyn Kim Robinson is a notable inventor based in Penn, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. With a total of 2 patents, Robinson's work is recognized for its innovative approach to addressing inflammatory disorders.

Latest Patents

Robinson's latest patents focus on antibodies against E-selectin. These inventions relate to whole antibodies of neutral isotype that have specificity for E-selectin. The patents detail a process for their preparation using vectors, as well as pharmaceutical compositions containing these antibodies. Their use in therapy and diagnosis is also highlighted. The antibodies are variants of natural antibodies that have been altered in the F region, particularly in the CH domain, to minimize interactions with antibody F receptors and complement.

Career Highlights

Martyn Kim Robinson is currently associated with Celltech Therapeutics Limited, where he continues to advance his research and development efforts. His work has contributed to the understanding and treatment of various inflammatory conditions, showcasing his commitment to improving healthcare through innovation.

Collaborations

Robinson collaborates with Raymond John Owens, further enhancing the research capabilities and innovative potential within his field.

Conclusion

Martyn Kim Robinson's contributions to antibody development exemplify the impact of innovation in biotechnology. His patents and ongoing work at Celltech Therapeutics Limited highlight the importance of research in addressing critical health challenges.